Capsule Filler & Capsule Filling Resources

CAPSULE FILLER & CAPSULE FILLING: PRODUCTS, SERVICES, WHITE PAPERS, AND ARTICLES

• Meeting Customers Where They Are With Mobile Technology

  Field Technologies Online talks with Panasonic’s Chad Hall about how rugged mobile solutions can close the gap in customer experience, increase workforce optimization, and level-up productivity for utility workers.

• Water And Hospitality Come Together To Tackle FOG

  Water companies are prioritizing engagement with the hospitality sector in their drive to keep sewers free of fats, oils and grease (FOG). Network protection managers at Southern Water and United Utilities, Stephen Williams and Andrew Peet, tell Laura Su, managing director of the European FOG Summit, why cross-sector partnerships must be forged.

• Understanding The White House's Get The Lead Out Partnership, With One Of Its Participants

  In late January, the White House welcomed over 100 organizations for the launch of the Biden-Harris Get the Lead Out Partnership, which seeks replacement of 100% of the nation’s lead service lines (LSLs) in 10 years. The organizations that were on hand come from various sectors, but all have a vested interest in ‘getting the lead out’ and improving water quality for consumers, and all have partnered with the Administration to achieve the lofty goal of complete LSL removal.

• Frequently Asked Questions: 2023 EMA And FDA Guidance

  Delve into critical questions posed by clinical trial teams regarding their awareness of new eCOA-related regulatory guidance published this year and what teams should know to ensure compliance is met.

• Revisiting Perspectives On 'Water For Development': Keys To Project Development And Financing

  A Q&A with Xavier Leflaive, Water Team Lead, Organisation for Economic Co-operation and Development (OECD) Environment Directorate

• Driving Quality And Speed In Data Acquisition

  Uncover how a clinical database programming team was able to ensure data quality, accelerating cycle times, and the overall success of a clinical trial.

• Putting PFAS In The Past Michelle Bellanca, CEO of cleantech company Claros Technologies, shares her thoughts on how to fix the nation's PFAS problem.
• Meet The Cardinal Health Regulatory Experts: Yin Lai, Ph.D, MSc, RAC

  As the emerging field of advanced therapies necessitates new regulatory submission processes which focus on manufacturing and CMC, learn how an experienced regulatory consultant can optimize the submission process and reduce delays on the path to approval.

• Understanding Closed Pipe Flow Measurement

  This recent Q&A with Richard Lowrie, KROHNE’s Water and Wastewater Industry Manager for the US and Canada, covers closed pipe measurement and its enabling technologies.

• CRISPR In The Clinic: Regulatory Experts Discuss Development Of Cell And Gene Therapies

  A regulatory expert provides her insight on what regulatory experts do and how they can help you accelerate your path from bench to clinic.

• Advancing Laser Technology: Ophir Discusses The Importance Of Measuring M2

  Reuven Silverman, Business Unit Manager at MKS, discusses the importance of M2 measurements in laser technology and Ophir’s innovative products for accurate laser analysis.

• How To Avoid Delays In Clinical Supply: Strategies For Comparator Sourcing

  Learn about the ways in which sponsors can work effectively with clinical suppliers for accurate forecasting and comparator sourcing.

• Advanced Tech Can Thwart Site Staffing Problems

  In clinical research, staffing shortages can delay trials and prevent new therapies from getting to patients in need. Read why Melissa Easy, VP, Clinical Technologies at IQVIA, believes advanced tech may bridge this gap as she reviews tools that are proving useful to study teams.

• Building A New Standard Of CDMO In Fishers, IN: Q&A With Cory Lewis, Founder And CEO

  Cory Lewis, CEO of INCOG Biopharma Services, explains how the company is adapting with rapid growth to deliver customizable and flexible solutions from early development support to commercial filling.

• How To Use Digital Technology To Increase Clinical Trial Diversity

  In this Q&A, Medable and Scott Treiber, Vice President, Strategic Development at Synteract delve into issues with clinical trial diversity, the FDA’s role and new guidance, and new technologies that can help.

• 7 Industry Leaders Weigh In On Patient Engagement & Recruitment

  Gain insights from leaders representing different facets of the clinical trial ecosystem regarding study activities and industry learnings that encourage successful trial outcomes.

• FAQs: What Is A Digital Water Platform, And How Will It Shape The Future?

  Here are a few most frequently asked questions about digital water platforms — what they are, how they benefit utilities, and how they will shape the future of the water industry.

• SMART On FHIR: The Future's So Bright, I Gotta Wear Shades

  During DIA 2023, SMART on FHIR and its promising future sparked numerous inquiries from media, clients, prospects, and industry leaders alike, prompting CEO Cal Collins to provide helpful insight.

• The Importance Of Gene Editing In Successful Cell Therapy

  Gene editing makes off-the-shelf cell therapies feasible by modifying cells to evade immune attack, improve overall compatibility, and prolong the survival of transplanted cells.

• The Role Of Allogeneic Treatments In The Future Of Cell Therapy

  Review considerations for a successful development and manufacturing process and learn how finding an experienced partner can help you overcome hurdles on the path to IND.

• How Leading CDMOs Are Driving A Greener Future For Pharma

  In response to a 2023 Open Letter from leading pharma companies, CDMOs are determining how to adapt their SOPs to improve sustainability and reduce CO2 emissions.

• Clinical Trials & Europe: Sponsor And CRO Feedback On Automating Participant Reimbursement

  Find out why sponsors and CROs in Europe are increasingly turning to technology to automate their patient engagement processes, garnering positive feedback from sites.

• The Power Of Patient Preferences: Technology And Payment Automation

  How can you leverage customizable, simplified payment methods and third-party providers to improve patient convenience in your clinical trial?

• Quantifying Sleep In The Real World

  ActiGraph Chief Scientific Officer Christine Guo speaks to Dr. Jennifer Walsh about her experiences and the surprising insights her team uncovered as they conducted the first RCT to deploy self-reports, actigraphy, and PSG to rigorously examine treatment effect of a medical cannabis product for insomnia.

• Aligning New Cancer Therapies With FDA Project FrontRunner

  Explore questions about the FDA’s Project FrontRunner, including what the project entails, trial design considerations and implications, and the impact on patient safety and site participation.

• Biotech And CAR-T Research In China

  Novotech hosted a webinar highlighting China’s rapidly expanding biotech research. After the event, experts answered questions on biotech and CAR T cell therapy research in China.

• How Sponsors Can Make It Easier For Rare Disease Patients And Families To Participate In Trials

  New research highlights several significant challenges sponsors encounter when conducting clinical trials in rare neurological disorders.

• Executive Q&A With SGS' Hudson, NH Bioanalytical Services Facility

  Explore how SGS's Hudson facility can enhance your drug development process by providing cutting-edge bioanalytical testing solutions and seamless global support.

• The Evolution Of The Cell And Gene Therapy Field

  Lung-I Cheng, Vice President, Cell and Gene Therapy, AmerisourceBergen, discusses emerging trends in the CGT market and details the value of leveraging the expertise of knowledgeable partners and stakeholders.

• A Year Of Reflection And Preparation

  The Trial Master File (TMF) landscape in 2025 will require companies to stay attuned to the evolving ICH E6(R3) guidelines and the full implementation of the CTIS.

• Strategies For De-Risking Early-Phase Oral Small Molecule Drug Development

  A team of experts discuss risk-reduction strategies, critical formulation considerations, and careful technology selection to stretch the often limited quantities of API available for early studies.

• Examining The Emergence Of Unit- And Bi-Dose Nasal Sprays

  Nasal spray administration of medicine offers advantages over oral and IV delivery. Experts discuss the advantages and opportunities of adopting unit- and bi-dose nasal delivery technology.

• Aligning Pediatric Patient Needs With Drug Development Success

  Executive Director of Pharmaceutical Sciences Srinivasan Shanmugam, Ph.D., discusses pediatric patient compliance, regulations impacting trial access, excipients within formulations, and more.

• How To Support At Every Stage Of The Clinical Cycle

  Alan Lahaise, VP, Business Development, Manufacturing and EMEA Clinical Services, discusses core clinical trials services, how to tackle the structural complexity of modern biologics, and regulatory considerations.

• Measuring Aspects Of Health In Heart Failure Research

  Dr. Bill Byrom sat with Cardiology Professor Marianna Fontana to discuss opportunities for measuring aspects of health meaningful for increasing the usefulness of COA measures in heart failure trials.

• Reduce The Environmental Footprint Of Oligonucleotides

  Industry experts answer attendees' questions from a recent webinar about sustainability concerns surrounding oligonucleotide manufacturing.

• Downstream Process Development Customer Service

  This question-and-answer session explores a variety of technical support services available to help in the implementation of Praesto™ chromatography resins.

• Sustainability Goals Impacting Biopharma

  What are some of the new trends in the pharmaceutical industry spurred on by mAbs and other advanced therapies, and how is sustainability influencing business practices?

• Optimizing Oncology And Rare Disease Clinical Trials By Focusing On Science And Aligning With Both Patients And Investigators

  Dive into the history and accomplishments of Ergomed, a mid-sized, full-service contract research organization (CRO), with a specialized focus on oncology and rare disease clinical research.

• A Guide To Protein Engineering

  Almost every facet of an antibody can be modified. Explore antibody humanization, the importance of affinity and function, isotype selection, and the development of bispecific and antibody-drug conjugates (ADCs).